Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemia
- 1 December 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27, S14-S17
- https://doi.org/10.1016/0277-5379(91)90557-t
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationBlood, 1988
- Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2bInvestigational New Drugs, 1987
- Clinical investigation of human alpha interferon in chronic myelogenous leukemiaBlood, 1987
- Chronic myelogenous leukaemia: haematological remissions with alpha interferonBritish Journal of Haematology, 1986
- Hydroxyurea and 6-Mercaptopurine in the Treatment of Chronic Granulocytic LeukemiaAmerican Journal of Clinical Oncology, 1986
- Bone Marrow Transplantation for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1986
- Chronic myelogenous leukemia: recent advancesBlood, 1985
- Prognostic discrimination in "good-risk" chronic granulocytic leukemiaBlood, 1984
- Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemiaBlood, 1983
- Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol)Blood, 1979